In a recent Fox News interview, Kennedy said "there's a lot of studies out there that show that if you actually do get the ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

A new treatment for Hodgkin lymphoma has been recommended for routine use ... suggests the combination could raise the amount ...

Dren Bio is currently evaluating the drug in two ongoing early-stage studies — B-cell non-Hodgkin lymphoma and autoimmune diseases. Sanofi believes that DR-0201 has the potential to reset the ...

Rescue therapies of relapsed/refractory (r/r) Hodgkin’s lymphoma (HL) in the third to sixth-line provide major, yet unresolved problems. The MEPED regimen includes nuclear receptor agonists such as ...

Several WHO officials recounted the impact the U.S. funding cuts are already having on disease control efforts in multiple countries, including the rollout of promising malaria vaccines and mass ...